AWH 0.99 (-33.56%)
US04537Y1091Medical Diagnostics & ResearchDiagnostics & Research

Aspira Womens Health (AWH) Competitor Comparison

We are evaluating the key criteria listed to compare Aspira Womens Health (AWH) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - AWH ranking 55 / 58

These are the competitors of Aspira Womens Health in the industry Diagnostics & Research ranked by linearity 3 years
1. Mettler-Toledo MTD
761.97
2. Quest Diagnostics DGX
77.4
3. Danaher DHR
68.85
4. DexCom DXCM
43.77
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. Thermo Fisher Scientific TMO
27.14
7. Natera NTRA
16.42
8. PerkinElmer PKI
16.14
9. Agilent Technologies A
15.35
10. Laboratory Corp of America Holdings LH
13.35
11. IQVIA Holdings IQV
12.97
12. Qiagen QGEN
12.15
13. Waters WAT
10.83
14. Syneos Health SYNH
10.68
15. Myriad Genetics MYGN
7.68
16. Heska HSKA
7.67
17. IDEXX Laboratories IDXX
7.23
18. Anixa Biosciences ANIX
5.82
19. Olink Holding OLK
5.4
20. Trinity Biotech TRIB
5.25
21. National Research NRC
4.4
22. Global Cord Blood CO
4.22
23. Charles River Laboratories CRL
4.1
24. Icon ICLR
4.07
25. Sotera Health SHC
3.73
26. Psychemedics PMD
3.29
27. Enzo Biochem ENZ
3.07
28. Sera Prognostics SERA
2.96
29. Exact Sciences EXAS
2.69
30. Neogen NEOG
2.6
31. Fulgent Genetics FLGT
2.39
32. Bioventus BVS
2.36
33. Illumina ILMN
2.29
34. NeoGenomics NEO
2.27
35. Inotiv NOTV
2.22
36. MDxHealth MDXH
2.15
37. Co-Diagnostics CODX
2.13
38. Twist Bioscience TWST
2.11
39. Guardant Health GH
2.06
40. MaxCyte MXCT
1.94
41. Prenetics Global PRE
1.89
42. bioAffinity Technologies BIAF
1.84
43. Organovo Holdings ONVO
1.79
44. Exagen XGN
1.78
45. Pacific Biosciences of California PACB
1.71
46. Interpace Biosciences IDXG
1.69
47. CareDx CDNA
1.66
48. Precipio PRPO
1.63
49. DarioHealth DRIO
1.62
50. Neuronetics STIM
1.61
51. Biodesix BDSX
1.54
52. Personalis PSNL
1.51
53. SeqLL SQL
1.48
54. RadNet RDNT
1.42
55. Aspira Womens Health AWH
1.38
56. Lantheus Holdings LNTH
1.33
57. Medpace Holdings MEDP
0.99
58. Meridian Bioscience VIVO
0.73

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.